Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 3, 2011, Pages 197-204

  Adeyemi, Oluwatoyin M ^a,b   Agniel, Denis ^a   French, Audrey L ^a,b   Tien, Phyllis C ^c   Weber, Kathleen ^a   Glesby, Marshall J ^d   Villacres, Maria C ^e   Sharma, Anjali ^f   Merenstein, Daniel ^g   Golub, Elizabeth T ^h,i   Meyer, William ^c   Cohen, Mardge ^a,b  

^a Jr Hospital of Cook County   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f SUNY Downstate Medical Center   (United States)

^g GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

HIV infected; HIV uninfected; vitamin D; vitamin D deficiency

Indexed keywords

EFAVIRENZ; PROTEINASE INHIBITOR; TENOFOVIR; VIRUS RNA; VITAMIN D;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MORBIDITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RISK; SERUM; UNITED STATES; VITAMIN D DEFICIENCY; WILCOXON SIGNED RANKS TEST;

ADULT; AFRICAN AMERICANS; ANTI-HIV AGENTS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; MIDDLE AGED; ODDS RATIO; RISK FACTORS; RNA, VIRAL; UNITED STATES; VITAMIN D DEFICIENCY;

EID: 79959763397     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31821ae418     Document Type: Article

References (34)

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-281.
2. Holick M, Chen T. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87:S1080-S1086.
3. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168: 1340-1349. (Pubitemid 351930842)
4. Giovannucci E, Liu Y, Hollis BW, et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008; 186:1174-1180. (Pubitemid 351831400)
5. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503-511.
6. Watson K, Abrolat M, Malone L, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation. 1997;96: 1775-1760.
7. Maalouf N. The noncalciotropic actions of vitamin D: recent clinical developments. Hypertension. 2008;17:408-415.
8. Garland CF, Comstock GW, Garland FC, et al. Serum 25-hydroxyvitamin D and colon cancer. Lancet. 1989;2:1176-1178.
9. Lin J, Mason JE, Lee IM, et al. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med. 2007;167:1050-1059. (Pubitemid 46835793)
10. Fiscella K, Franks P. Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med. 2010;8:11-18.
11. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;167:1159-1165. (Pubitemid 46919818)
12. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009;169:626-632.
13. Gyllensten K, Josephson F, Lidman K, et al. Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59 degrees N. AIDS. 2006;20: 1906-1907. (Pubitemid 44358915)
14. Brown T, McComsey G. Association between initiation of anti-retroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther. 2009;14(suppl 2):A15.
15. Fabbriciani G, De Socio GV. Efavirenz and bone health. AIDS. 2009; 23:1181.
16. Van Den Bout-Van Den Beukel CJ, Fievez L, Michaels M, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses. 2008;24: 1375-1382.
17. Rodriguez M, Daniels B, Gunawardene S, et al. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses. 2009;25:9-14.
18. Mehta S, Giovannucci E, Mugusi FM, et al. Vitamin D status of HIVinfected women and its association with HIV disease progression, anemia, and mortality. PLoS One. 2010;5:e8770.
19. Bang UC, Shakar SA, Hitz MF, et al. Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study. Scand J Infect Dis. 2010;42:306-310.
20. Mueller NJ, Fux CA, Ledergerber B, et al; the Swiss HIV Cohort Study. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS. 2010; 24:1127-1134.
21. Dao CN, Patel P, Overton TE, et al. Low vitamin D among HIVinfected adults: prevalence of and risk factors for low vitamin D levels in a cohort of HIV-Infected adults and comparison to prevalence among adults in the general US population. Clin Infect Dis. 2011;52: 396-405.
22. Stephensen CB, Marquis GS, Kruzich LA, et al. Vitamin D status in adolescents and young adults with HIV infection. Am J Clin Nutr. 2006; 83:1135-1141. (Pubitemid 44713115)
23. Bacon MC, Von Wyl V, Alden C, et al. The Women's Interagency HIV Study: an observational cohort brings clinical science to the bench. Clin Diagn Lab Immunol. 2005;12:1013-1019. (Pubitemid 41324530)
24. Barkan SE, Melnick SL, Preston-martin S, et al. The Women's Interagency HIV Study. WIHS Collaborative study group. Epidemiology. 1998;9:117-125. (Pubitemid 28157608)
25. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
26. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab. 2010;95:471-478.
27. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690-693. (Pubitemid 30667088)
28. Freedman B, WagenKnecht LE, Hairston KG, et al. Vitamin D, adiposity, and calcified atherosclerotic plaque in African Americans. J Clin Endocrinol Metab. 2010;95:1076-1083.
29. Nesby-O'Dell S, Scanlon KS, Cogwell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age; Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002;76:187-192. (Pubitemid 34686565)
30. Scragg R, Camargo CA. Frequency of leisure time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2008;168:577-586.
31. LaClair RE, Hellman SR, Karp SL, et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005;45:1026-1033. (Pubitemid 40806515)
32. Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium and phosphorous in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31-38. (Pubitemid 44967731)
33. Stavroulopoulos A, Porter CJ, Roe SD, et al. Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4. Nephrology. 2008;13:63-67.
34. Overton ET, Yin MT. The rapidly evolving research on vitamin D among HIV-infected populations. Curr Infect Dis Rep. 2011;13:83-93.